Best Evidence Interviews in Cardiology

 
 
  • Beef, Microbes in the Gut, and Heart Disease Medscape talks to Dr. Stanley Hazen about his studies finding that the metabolism by gut microbes of common nutrients found in red meant may account for the residual risk for cardiovascular disease.
  • The Diuretic Duel: Still 2 Options? Medscape interviewed Dr. Irfan A. Dhalla concerning a surprising study that questions the benefit of chlorthalidone over hydrochlorothiazide for treating hypertension.
  • Aspirin in Pregnancy: Beyond Preeclampsia Medscape talks to Dr. Emmanuel Bujold about the latest evidence on the use of prophylactic low-dose aspirin in pregnancy and benefits that go beyond preeclampsia.
  • The PUFA Investigation: An Expert Interview Medscape interviewed Christopher Ramsden concerning the study showing a higher risk for mortality in patients consuming linoleic acid compared to those eating saturated fats.
  • Renal Denervation: Is Reality Meeting Expectations? Medscape interviewed Michel Azizi, the lead author on a study reporting on real-life conditions for renal denervation in resistant hypertension.
  • The Third MI Definition: Expert Interview With Joseph Alpert In this Medscape Interview, Joseph S. Alpert, MD, the lead coauthor of the 2012 third universal definition of myocardial infarction, talks about the significant changes in this important document.
  • Chest Pain and Predicting CAD: Time to Change the Guidelines? In this Medscape interview, M.G. Myriam Hunink, MD, PhD, talks about an important new prediction model, which is intended to improve how the probability of obstructive coronary artery disease is estimated.
  • Time to Offer a Polypill to People Aged 50 or Over? Medscape talks to Dr. David Wald, who coordinates the Polypill Prevention Programme, about the latest research on the polypill and whether it's time to use it for primary prevention.
  • Back to Basics: Latest European Guidelines on CVD Prevention Medscape interviewed Joep Perk, MD, about 2012 clinical guidelines prepared by the Fifth Joint Task Force on Cardiovascular Disease Prevention. He gives us a refreshing inside story to reduce guideline lethargy.
  • S-ICD: Game-Changer in Preventing Sudden Cardiac Death In this Medscape interview, Martin Burke discusses the new subcutaneous implantable cardioverter-defibrillator and why this device is important for both cardiologists and primary care physicians.
  • CRP as a Predictor of Statin Efficacy: Time to Move On? Medscape interviewed Peter Sever, Co-Chair of ASCOT, about putting to rest the idea that reducing C-reactive protein with a statin has any cardiovascular benefits beyond lowering LDL cholesterol.
  • Heart Failure Diagnosis: Not a Death Sentence Medscape interviewed Mihai Gheorghiade, MD, concerning the IMPROVE-HF study that provided support a new paradigm for how heart failure should be viewed and treated.
  • Gout and the Antihypertensives The risk of gout is high in patients with hypertension. Which classes of antihypertensive drugs augment that risk? Which classes of drugs reduce it?
  • Aspirin in Primary Prevention: Interview With Kausik Ray Prof. Kausik Ray explains why aspirin for primary prevention is not one-size-fits-all. When do the benefits outweigh the risks? Where does cancer prevention fit into this equation?
  • Will the Real Risk Factors Stand Up: A Surprise From Bogalusa Medscape talks to Gerald S. Berenson, MD, about one of the last studies coming out of the Bogalusa Heart Study, with surprising findings on LDL-C and obesity as risk factors for future heart disease.
  • Vitamins and Mortality: An Interview With Jaakko Mursu In this expert interview, Medscape talks to Jaakko Mursu, the lead author of a study that reported higher mortality rates associated with certain supplements.
  • CCTA for Acute Chest Pain: Will It Become Routine? Medscape interviewed Gilbert Raff, concerning the CT-STAT trial, that reported on the value of coronary CT angiography in assessing acute chest pain.
  • Afib and CKD: How Strong Is That Link? Medscape interviews Charles Herzog, MD, to help clinicians understand the association between chronic kidney disease and atrial fibrillation and how to manage it.
  • The NSAID and CVD Balancing Act Medscape interviews Daniel Solomon, MD, who provides the rheumatologist viewpoint on balancing the risks for cardiovascular events with the need for pain control using NSAIDs.
  • Too Many ICDs? What's Appropriate for Implantation? Medscape interviews Brian Olshansky, MD, concerning a JAMA study reporting that 20% of patients received implantable cardioverter defibrillators that were "nonevidence" based.